1. Haffer AS, Rogers JR, Montello MJ, Frank EC, Ostroff C. 2001 anthrax crisis in Washington D.C.: clinic for persons exposed to contaminated mail. Am J Health-Syst Pharm 2002;59:1189-92.
2. Montello MJ, Ostroff C, Frank EC, Haffer AS, Rogers JR. 2001 anthrax crisis in Washington, D.C.: pharmacists' role in screening patients and selecting prophylaxis. Am J Health-Syst Pharm 2002;59:1193-9.
3. "Three-day bioterrorism drill begins in an Oklahoma town." Associated Press. The New York Times 2002; April 13:A11.
4. "Official react to bioterrorism drill." Brown, JL. The Washington Post. 2002; April 12. URL: www.washingtonpost.com/wp-dyn/articles/A36763-2002Apr12.html. Accessed 9/10/02.
5. Inglesby TV. Observations from the Top Off exercise. Public Health Reports 2001 Supplement 2;116:64-75.
6. Osterholm MT. How to vaccinate 30,000 people in three days: realities of outbreak management. Public Health Reports 2001 Supplement 2;116:74-8.
7. "Guidelines for the development of a local action plan for use of the following assets: state pharmaceutical stockpile (SPS) and Strategic National Stockpile(SNS)." Florida Department of Health, Office of Emergency Operations. April 2002.
8. "National pharmaceutical stockpile: guidelines for counties." Central Florida Regional Domestic Security Task Force. Draft Version 3. August 16, 2002.
9. State of California Mass Prophylaxis Planning Guide. Emergency Medical Services Authority of California. 2003. Available at: www.emsa.cahwnet.gov/dms2/draft_mass_prophy_final.pdf. Accessed April 2, 2004.
10. Smallpox Response Plan and Guidelines (Version 3.0). Centers for Disease Control and Prevention. Web Site: www.bt.cdc.gov/agent/smallpox/response-plan/index.asp. Accessed on February 21, 2003.
11. "Anthrax clinical pathways for clinics (updated 01/09/02)." SUMC Bioterrorism and Emergency Preparedness Task Force, Stanford University Medical Center. URL: www.stanfordhospital.com/pdf/bioterrorism/anthraxclinicalpathwaysclinics.pdf. Accessed 9/10/02.
12. "Suspected exposure to bioterrorism agent emergency department triage guidelines (updated 12/08/01)." SUMC Bioterrorism and Emergency Preparedness Task Force, Stanford University Medical Center. URL: www.stanfordhospital.com/pdf/bioterrorism/EDTriageGuideline.pdf. Accessed 9/10/02.
13. "Bioterrorism preparedness checklist—local public health agency perspective." Layton, M. Informal Discussions on Strengthening National Preparedness and Response to Biological Weapons; World Health Organization. March 6-8, 2002. URL: www.who.int/emc/pdfs/Marcy%20Layton.pdf. Accessed 9/10/02.
14. "Infrastructure, organizational, policy, and resource implications for implementing CDC guidelines for managing and using a deployed national pharmaceutical stockpile." NACCHO planning document 8/02.
15. "Prototype position description for the top manager for coordination and support of a statewide SNS preparedness program." NACCHO planning document 8/02.
16. Clearinghouse records of city, county, and state emergency preparedness plans. NACCHO. URL: http://bt.naccho.org/print.asp. Accessed 9/10/02.
17. Landesman LY. Public health management of disasters: a practice guide. Washington, D.C.: American Public Health Association; 2001.
18. Auf der Heide, E. Disaster Response: Principles of Preparation and Coordination. Center for Excellence in Disaster Management & Humanitarian Assistance: Honolulu, 2001. Chapter 8: Triage. URL: http://216.202.128.19/dr/DisasterResponse.nsf/section/08?opendocument. Accessed 9/10/02.
19. "CERT-Los Angeles: simple triage and rapid treatment." URL: www.cert-la.com/triage/start.htm. Accessed 9/10/02.
20. "Health disaster management: guidelines for evaluation and research in the Utstein style: executive summary." Task Force on Quality Control of Disaster Management. URL: http://pdm.medicine.wise.edu/executiv2.htm. Accessed 9/10/02.
21. Hamburg MA. Challenges confronting public health agencies. Public Health Reports 2001 Supplement 2;116:59-63.
22. Glass TA. Understanding public response to disasters. Public Health Reports 2001 Supplement 2;116:69-73.
23. O'Toole T, Inglesby TV. Epidemic response scenario: decision making in a time of plague. Public Health Reports 2001 Supplement 2;116:92-103.
24. O'Toole, T. The problem of biological weapons: next steps for the nation. Public Health Reports 2001 Supplement 2;116:108-11.
25. Fee E, Brown TM. Preemptive biopreparedness: can we learn anything from history? American J of Pub Health 2001 May; 91(5):721-6.
26. Rubin J. Institutional networks: regional response to disasters. Public Health Reports 2001 Supplement 2;116:45-8.
27. Kuhr S, Hauer JM. Intergovernmental preparedness and response to potential catastrophic biological terrorism. J of Pub Health Management and Practice 2000 July;64(4):50-6.
28. Bartlett JG. Mobilizing professional communities. Public Health Reports 2001 Supplement 2;116:40-4.
29. The Treatment of Mass Civilian Casualities in a National Emergency. McCarroll JR, Skudder PA, Eds. Medical Education for National Defense, Washington, D.C. 1967.
30. Summary Report on National Emergency Medical Care. The American Medical Association, Chicago, IL. 1959.
31. Community Outreach—Mass Prophylaxis: A Mass Casualty Care Strategy for Biological Terrorism Incidents. US Army Soldier and Biological Chemical Command, Homeland Defense Office, Department of Defense; June 1, 2002.
32. Inglesby TV. Preparedness for terrorist attack. Federal Document Clearing House Congressional Testimony. Capitol Hill Hearing Testimony. Senate Governmental Affairs. April 18, 2002 Thursday.
33. Ridge T. National Incident Management System. Washington, DC: Department of Homeland Security; March 2004.
34. Bentley JD. Hospital preparedness for bioterrorism. Public Health Reports 2001 Supplement 2;116:36-9.
35. Bloem K. Treating the sick: capacity of the US health care system to respond to an epidemic. Public Health Reports 2001 Supplement 2;116:34-5.
36. Wetter DC, Daniell WE, Treser CD. Hospital preparedness for victims of chemical or biological terrorism. American J of Pub Health 2001 May; 91(5):710-6.
37. Giovachino M, Carey N. Modeling the consequences of bioterrorism response. Mil Med 2001;166(11):925-30.
38. Johnson LA. Hospitals, state health system readying staff, equipment for terrorism. Associated Press. BC Cycle; June 6, 2002.
39. 17 Critical Benchmarks for Bioterrorism Preparedness Planning. FDCH Federal Department and Agency Documents. Regulatory Intelligence Data. Department of Health and Human Services. June 6, 2002.
40. California Hospital Bioterrorism Response Planning Guide. California Department of Health Services and Emergency Medical Services Authority of California. June, 2002. URL: www.emsa.cahwnet.gov/dms2/ca_hosp_guide.pdf. Accessed 9/10/02.
41. "Technical assistance for anthrax response," Interim-Final Draft for Review June 2002. National Response Team. 2002, August 2.
42. Kennedy EM. National leadership in confronting bioterrorism: 2. Public Health Reports 2001 Supplement 2;116:116-8.
43. Knouss RF. National disaster medical system. Public Health Reports 2001 Supplement 2;116:49-52.
44. Bravata D, McDonald K, Owens D, et al. Bioterrorism Preparedness and Response: Use of Information Technologies and Decision Support Systems: Evidence Report/Technology Assessment No. 59 (Prepared by University of California San Francisco-Stanford Evidence-based Practice Center under Contract No. 290-97-0013). AHRQ Publication No. 02-E028. Rockville, MD: Agency for Healthcare Research and Quality. June 2002.
45. "Biological and chemical terrorism: strategic plan for preparedness and response." Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report: Recommendations and Reports 2000, April 21; 49(RR-4):1-14.
46. "Prevention and control of influenza: recommendations of the advisory committee on immunization practices." Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report 2002, April 12;51(RR-3):1-31.
47. "Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001." Centers for Disease Control and Preparedness. Morbidity and Mortality Weekly Report 2001 October 26; 50(42):909-19.
48. Phillips S, Burstin H, Dillard CD, Clancy CM. AHRQ's bioterrorism research portfolio: real linkages in real time. Health Serv Res Feb 2004;39(1):xi-v.
49. "Public health response to biological and chemical weapons." WHO Guidelines. World Health Organization; November 2001.
50. Receiving, Distributing, and Dispensing the National Pharmaceutical Stockpile: A Guide for Planners. Version 9—Draft. Centers for Disease Control and Prevention; April 2002.
51. Smallpox Response Plan and Guidelines (Version 3.0). Centers for Disease Control and Prevention. Web Site: www.bt.cdc.gov/agent/smallpox/response-plan/index.asp. Accessed on February 21, 2003.
52. Henderson DA, Inglesby TV, Bartlett JG, Ascher MS, Eitzen E, Jahrling PB, et al. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999;281(22):2127-37.
53. Mack T. A different view of smallpox and vaccination. N Engl J Med 2003;348(5):460-3.
54. Fauci AS. Smallpox vaccination policy—the need for dialogue. N Engl J Med 2002;346(17):1319-20.
55. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med 2002;346(17):1300-8.
56. Kaplan EH, Craft DL, Wein LM. Emergency response to a smallpox attack: the case for mass vaccination. Proc Nat Acad Sci United States of America. 2002;99(16):10935-40.
57. Halloran ME, Longini IM, Jr., Nizam A, Yang Y. Containing bioterrorist smallpox. Science 2002;298(5597):1428-32.
58. Bozzette SA, Boer R, Bhatnagar V, et al. A model for a smallpox-vaccination policy. N Engl J Med 2003;348(5):416-25.
59. Galea S, Ahern J, Resnick H, et al. Psychological sequelae of the September 11 terrorist attacks in New York City. N Eng J Med 2002;346(13):982-7.
60. Hoge CW, Pavlin JA. To the editor: psychological sequelae of September 11. N Eng J Med 2002;347(6):443-4.
61. Yehuda R. Post-traumatic stress disorder. N Eng J Med 2002;346(2):108-30.
62. Holloway HC, Norwood AE, Fullerton CS, Engel CC, Ursano RJ. The threat of biological weapons: prophylaxis and mitigation of psychological and social consequences. JAMA 1997;278(5):425-7.
63. Glass TA, Schoch-Spana M. Bioterrorism and the people: how to vaccinate against panic. Clin Infect Dis 2002 Jan 15;34(2):217-23.